The Effects of Individualized Respiratory Exercise Device in Healthy Individuals
NCT06245928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-12-15
Summary
Respiratory exercise devices can be grouped as respiratory muscle training (RMT) devices and incentive spirometers (IS). IS can improve pulmonary ventilation using visual feedback but cannot increase respiratory muscle strength. RMT devices strengthen the respiratory muscles by their resistance mechanisms but they cannot provide visual feedback. It has been stated that RMT increases exercise performance in healthy individuals. RMT devices usually allow only one of inspiratory muscle training or expiratory muscle training. The need to acquire 2 devices for combined training increases the cost. It is seen that the RMT devices available in Turkey do not allow combined training and a significant part of them do not offer sufficient loading range.
The aims of the project are; to develop a multifunctional individualized respiratory exercise device originating in Turkey, and to analyze the clinical effects of an individualized respiratory exercise device on pulmonary function, respiratory muscle strength, and functional capacity in healthy individuals. The device to be developed in this project will be the first multifunctional respiratory exercise device originated in Turkey. The device will have the clinical features of IS and RMT devices and can be individualized according to the desired purpose. With the same device, the individual will be able to both improve the ventilation of the lungs like the IS and strengthen the respiratory muscles in the direction of inspiration and/or expiration with wide loading intervals.
A total of 46 healthy individuals will be included in the study. The healthy individuals included in the study will be randomly divided into two groups experimental group (n=23) and control group (n=23). The individuals in the experimental group will be trained with an individualized respiratory exercise device for 5 days a week for 8 weeks. The individuals in the control group will be trained with Threshold® IMT + Threshold™ PEP training for 5 days a week for 8 weeks. In both groups, pulmonary function, respiratory muscle strength, and functional capacity will be assessed before and after the 8 weeks of training.
Conditions
- Healthy
Interventions
- DEVICE
-
Individualized Respiratory Exercise Device
The Individualized Respiratory Exercise device will include both inspiratory muscle training, expiratory muscle training, and intensive spirometer features.
- DEVICE
-
Threshold® IMT + Threshold™ PEP
The Threshold® IMT device allows inspiratory muscle training and the Threshold™ PEP device allows expiratory muscle training.
Sponsors & Collaborators
-
The Scientific and Technological Research Council of Turkey
collaborator OTHER -
Biruni University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2025-05-01
- Completion
- 2025-05-01
Countries
- Turkey (Türkiye)
Study Locations
Related Clinical Trials
-
IRAD2 : Patients With Respiratory Failure at Home
NCT00230984 · Status: COMPLETED · Phase: PHASE3
- Chronic Respiratory Failure
- Nutritional Depletion
-
Thora-3Di™ Respiratory Rate Validation
NCT02374554 · Status: UNKNOWN · Phase: NA
- Pulmonary Disease
-
Oxygen Reserve Index Validation for RD Lite Sensors
NCT03128892 · Status: COMPLETED
- Healthy
-
Sleepiz One+ Versus Capnography and Electrocardiography
NCT05712226 · Status: COMPLETED · Phase: NA
- COPD
- Hypertension
- Sleep Apnea
- +3 more
-
Structured Light Plethysmography Against Standard of Care in the Diagnosis and Monitoring of Dysfunctional Breathing
NCT04255446 · Status: NOT_YET_RECRUITING
- Dysfunctional Breathing
More Related Trials
-
Comparison Between Different Technologies That Measure Respiratory Rate
NCT02657720 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure
NCT02497937 ·Status: COMPLETED ·Phase: PHASE2
-
Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)
NCT03492359 ·Status: COMPLETED ·Phase: NA
-
RespiraSense Versus Capnography & Manual Counting
NCT03148873 ·Status: COMPLETED
-
Automated Titration for Home Oxygen Therapy
NCT06153485 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
ORCHARD- Optimising Home Assessment of Rural Patients
NCT05732922 ·Status: COMPLETED ·Phase: NA
-
TorEx Lung Perfusion System
NCT05656404 ·Status: COMPLETED ·Phase: NA
-
Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety
NCT05427708 ·Status: RECRUITING ·Phase: NA
-
Oxygen Reserve Index (ORi) Validation of INVSENSOR00029
NCT03678103 ·Status: COMPLETED
-
Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00029
NCT04079842 ·Status: COMPLETED
-
Respiratory Biofeedback Sensor for Yoga Practice for Youth With Chronic Pain.
NCT05791435 ·Status: COMPLETED ·Phase: NA
-
Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025
NCT04079816 ·Status: COMPLETED
-
The Simplify Project
NCT05011877 ·Status: RECRUITING
-
Database of Patients Treated With Respiratory Support
NCT01181869 ·Status: UNKNOWN
-
Teledi@Log - Tele-rehabilitation of Heart Patients
NCT01752192 ·Status: COMPLETED ·Phase: NA
-
Capnography Library - Data Collection in the Critical Care Environment Stage 2
NCT01354769 ·Status: COMPLETED
-
Use of Orotracheal Continuous Positive Airway Pressure (CPAP) in Newborns With Respiratory Failure
NCT01379820 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy
NCT06375369 ·Status: RECRUITING ·Phase: NA
-
On the PhonE Respiratory rAte Study (OPERA)
NCT04077593 ·Status: COMPLETED
-
Evaluation of Sores Treatment by Oxygenotherapy
NCT03200353 ·Status: UNKNOWN ·Phase: NA
-
Prospective Validation of the ROX Index
NCT02845128 ·Status: COMPLETED
-
International Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry
NCT03135730 ·Status: RECRUITING